Status:
ACTIVE_NOT_RECRUITING
An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
HCM - Hypertrophic Cardiomyopathy
S-ICD System (implantable Defibrillator)
Eligibility:
All Genders
14+ years
Brief Summary
1. To observe the failure rate of S-ICD screening in HCM patients at high risk of SCD. 2. To observe the incidence of IAS in HCM patients with S-ICD implantation and explore the related factors of IAS...
Detailed Description
The study was a multicenter, prospective, observational study that prospectively included HCM patients assessed as meeting the ICD implantation indication at Fuwai Hospital and National Collaborative ...
Eligibility Criteria
Inclusion
- HCM patients assessed as meeting the ICD implantation indication
Exclusion
- Combined with bradycardia with pacing indications;
- Frequent monomorphic ventricular tachycardia require ATP therapy;
- With indications of CRT;
- Combined with other diseases, life expectancy is less than 1 year.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
589 Patients enrolled
Trial Details
Trial ID
NCT06604169
Start Date
August 1 2024
End Date
July 31 2028
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai hospital
Beijing, China, China, 100037